| For Practicing Oncologists |
  See all
 | Articles: Lung/Thoracic Oncology |
Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
Lung Cancer, 05/16/08
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
Lung Cancer, 05/16/08
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
Cancer Chemotherapy and Pharmacology, 05/16/08
Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers
Journal of Thoracic Oncology, 05/16/08
Alteration of APE1/ref-1 expression in non-small cell lung cancer: The implications of impaired extracellular superoxide dismutase and catalase antioxidant systems
Lung Cancer, 05/16/08
Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer
Lung Cancer, 05/16/08
Intrapleural etoposide for malignant effusion
Cancer Chemotherapy and Pharmacology, 05/16/08
Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan
International Journal of Clinical Oncology, 05/16/08
Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma
Modern Pathology, 05/15/08
Targeting growth factors in lung cancer
Chest, 05/15/08
|
|
Receive daily email updates on Lung/Thoracic Oncology
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
|
| Sponsor |
|
|
| Sponsor |
|
